2021

Senate

Record of Committee Proceedings

Committee on Health

Clearinghouse Rule 20-080

Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.

Submitted by Controlled Substances Board

March 24, 2021           Referred to Committee on Health

May 07, 2021              no action taken

______________________________

Heather Smith

Committee Clerk